Articles

Poll

Podcasts

Slideshows

Videos

Pain

The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.

As the treatment paradigm for neurologic diseases rapidly progresses, the need for more thorough biomarker tools to measure disease progression and severity has increased. In recent years, GFAP has emerged as a valuable candidate to add to the existing panel.

Building the Biomarker Panel in Neurology: Glial Fibrillary Acidic Protein

According to investigators, pulmonary hypertension indicates an increased risk of mortality in patients with systemic sclerosis. 

Higher Mortality Rates in Patients With Systemic Sclerosis-Associated Pulmonary Hypertension 

“In recent years, the habit of delaying pregnancy because of social and economic reasons has become more common, increasing the possibility of getting pregnant after the onset of the disease," investigators stated. "This fact makes pregnancy a more frequent issue to deal with in the present years.”

Systemic Sclerosis Increases Risk of Adverse Pregnancy Outcomes

A retrospective study analyzed patients with systemic sclerosis to determine prevalence, severity, and mortality within this patient population. 

Worse COVID-19 Outcomes Seen in Patients With Systemic Sclerosis

Clinicians have begun to incorporate more holistic ways to approach the treatment of multiple sclerosis symptoms by focusing on better overall health, exercising, and dieting.

The Expansion Toward Integrative Wellness Approaches in MS Care

Hypertension rates were low in both ulcerative colitis and multiple sclerosis patients treated with ozanimod, regardless of concurrent SNRI/SSRI use. 

Serotonin Syndrome Rates Low in Ozanimod Treated Ulcerative Colitis Patients

The results echo the previous understanding of MS specialists as well as add to the literature that has been collected thus far from other assessments.
 

Severe COVID-19 Outcomes for MS Patients Linked to Several Factors

Recent studies show efficacy and safety for both lemborexant and ozanimod.

New Agents Available for Insomnia and Multiple Sclerosis

Ponesimod reduced fatigue-related symptoms in phase 3 clinical trial.

Janssen Submits NDA for New Multiple Sclerosis Drug

Hospitals are preparing to treat MS patients safely in the wake of fears over the global pandemic.

Stakeholders Discuss Impact of COVID-19 on MS Patients

On the HCPLive multiple sclerosis page, resources on the topics of medical news and expert insight into MS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on primary progress and relapsing-remitting multiple sclerosis, and more.